Edwin M. Posadas

Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.

Lori Minasian, Liang Cao, Christina M. Annunziata, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases

Shuang Hou, Hsian-Rong Tseng, Ker-Chau Li, 2015, Cancer.

NanoVelcro rare‐cell assays for detection and characterization of circulating tumor cells☆

Shuang Hou, Matthew Smalley, Hsian-Rong Tseng, 2018, Advanced drug delivery reviews.

miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer

Dror Berel, Andre Rogatko, Ladan Fazli, 2014, Clinical Cancer Research.

A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer

Shuang Hou, Yong Hou, Huanming Yang, 2015, Oncotarget.

Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells

Shuang Hou, Hsian-Rong Tseng, H. Tseng, 2016, Theranostics.

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial

Michael J. Morris, Howard I. Scher, Ajjai Alva, 2018, JAMA oncology.